Predictive Factors for Occlusal Changes in Obstructive Sleep Apnea Treatment With Mandibular Advancement Appliance
Launched by UNIVERSITY HOSPITAL, TOULOUSE · Aug 26, 2024
Trial Information
Current as of July 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how certain factors affect changes in teeth alignment (occlusion) for people using a device called a mandibular advancement appliance (MAD) to treat obstructive sleep apnea syndrome (OSAS). OSAS is a common sleep disorder that affects around 6-12% of adults in France and can often lead to difficulties with treatment adherence. The researchers aim to understand how the use of MADs impacts the jaw muscles and teeth over six months, helping to personalize treatment plans and reduce the number of people who stop using these devices.
To participate in this study, individuals should have all their adult teeth, have been diagnosed with OSAS, and be receiving treatment at a specific hospital. Participants will need to provide consent and undergo some tests, including X-rays. Those who are pregnant, breastfeeding, or unable to give consent cannot join the trial. Overall, this research could provide important insights into improving the effectiveness of sleep apnea treatments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient with complete dentition (up to second molars)
- • Polysomnography or polygraphy
- • Diagnosis of OSA
- • Patient receiving OAM treatment at the Odontology Department of Toulouse University Hospital
- • Patient with contemporary panoramic and lateral cephalometric X-rays (common practice) taken at the time of orthotic treatment
- • Individual affiliated with or covered by a social security scheme
- • Voluntary, informed, written consent, signed by both participant and investigator (prior to inclusion and any necessary research-related examinations).
- Exclusion Criteria:
- • Inability to provide informed consent
- • Pregnant or breastfeeding patient
- • Patient with curators, guardians, or legal protection
About University Hospital, Toulouse
The University Hospital of Toulouse is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific inquiry with comprehensive clinical services. Its multidisciplinary team of healthcare professionals collaborates with renowned researchers to facilitate pioneering studies across various medical fields, aiming to enhance treatment options and improve patient outcomes. As a prominent institution in the region, the University Hospital of Toulouse is committed to fostering an environment of excellence in both education and research within the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Constance CUNY, MD
Principal Investigator
University Hospital, Toulouse
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported